Varian Medical Systems has acquired 73.5% of MeVis Medical Solutions AG to enhance its market presence and product offerings in the European healthcare sector.
Target Information
Varian Medical Systems, Inc., based in Palo Alto, California, is a global leader in the development of medical systems and software for the treatment of cancer and other diseases through radiotherapy, radiosurgery, and brachytherapy. In 2014, the company reported a revenue of USD 3.0 billion and employs approximately 6,800 staff across its manufacturing facilities in North America, Europe, and China. Additionally, Varian is a key supplier of tubes and digital detectors for X-ray equipment used in medical, scientific, and industrial applications, and it produces X-ray systems for the inspection of cargo containers and industrial assessment.
On January 27, 2015, Varian Medical Systems announced its acquisition of 73.5% of the share capital of MeVis Medical Solutions AG, a publicly listed company based in Bremen, Germany. This acquisition was executed through its subsidiary, VMS Deutschland Holdings GmbH, offering shareholders EUR 17.50 per share, amounting to an equity valuation of EUR 30 million. Network Corporate Finance exclusively advised Varian Medical Systems during this transaction.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
The healthcare industry in Germany is known for its innovative practices and advanced technology, making it one of the largest and most competitive markets in Europe. The German healthcare sector is characterized by a high deman
Similar Deals
Ephios Luxembourg S.a.r.l. → SYNLAB AG
2023
Medtronic plc → Anteris Technologies Global Corp.
2026
Varian Medical Systems, Inc.
invested in
MeVis Medical Solutions AG
in 2015
in a Public-to-Private (P2P) deal
Disclosed details
Transaction Size: $24M
Revenue: $3,000M
Enterprise Value: $30M
Equity Value: $30M